Diffusion Pharmaceuticals Reports 2019 Financial Results and Provides Business Update
$16.2 Million in Gross Proceeds RaisedNow Enrolling in Acute Stroke TrialGBM Data PresentedNew Board AppointmentCHARLOTTESVILLE, Va., March 17, 2020 (GLOBE […]
MOUNTAIN BOY TO BE GRANTED AMERICAN CREEK WEST WORK PERMIT & APPOINTS BEN WHITING TO THE BOARD OF DIRECTORS
VANCOUVER, British Columbia, March 17, 2020 (GLOBE NEWSWIRE) — Mountain Boy Minerals Ltd (“Mountain Boy” or the “Company”) (TSX.V: MTB; […]
Arbor Realty Trust Announces $100 Million Share Repurchase Program
UNIONDALE, N.Y., March 17, 2020 (GLOBE NEWSWIRE) — Arbor Realty Trust, Inc. (NYSE: ABR), today announced that its Board of […]
Performant Financial Corporation Announces Financial Results for Fourth Quarter and Full Year 2019
LIVERMORE, Calif., March 17, 2020 (GLOBE NEWSWIRE) — Performant Financial Corporation (Nasdaq: PFMT), a leading provider of technology-enabled recovery and […]
Karyopharm Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
NEWTON, Mass., March 17, 2020 (GLOBE NEWSWIRE) — Karyopharm Therapeutics Inc. (Nasdaq: KPTI), an oncology-focused pharmaceutical company, today announced that […]
Gevo Reports Fourth Quarter 2019 Financial Results
ENGLEWOOD, Colo., March 17, 2020 (GLOBE NEWSWIRE) — Gevo, Inc. (NASDAQ: GEVO) today announced financial results for the fourth quarter […]
Lightbridge Provides Business Update and Announces Fiscal Year 2019 Earnings Results
RESTON, Va., March 17, 2020 (GLOBE NEWSWIRE) — Lightbridge Corporation (NASDAQ: LTBR), an advanced nuclear fuel technology company, today announced […]
Cue Biopharma Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights
Extended cash runway with $33.3 million from at-the-market equity offerings in Q4’19Focused and effective execution of clinical development of CUE-101 […]
Exela Technologies Completes $40 Million Divestment of SourceHOV Tax as Part of Strategic Plan to Sell Non-Core Business Assets
IRVING, Texas, March 17, 2020 (GLOBE NEWSWIRE) — Exela Technologies, Inc. (“Exela” or the “Company”) (NASDAQ: XELA), a location-agnostic global business […]
NGM Bio Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights
–Successfully completed 24-week Phase 2 study (Cohort 4) of aldafermin in non-alcoholic steatohepatitis (NASH) patients, and announced topline results demonstrating […]
